Core Viewpoint - The company has approved a share buyback plan, indicating confidence in its business outlook and aiming to create value for shareholders [1] Summary by Relevant Sections - Share Buyback Authorization - The board has resolved to exercise its authority under the share buyback mandate to repurchase shares in the open market for a maximum total price of 40 million HKD [1] - Rationale for Buyback - The board believes that the share buyback reflects the company's confidence in its business prospects and will ultimately benefit the company and create value for shareholders [1] - Financial Position - The board is confident that the company's current financial resources will allow it to implement the proposed share buyback while maintaining a robust financial position [1] - Best Interests of Shareholders - The board considers the proposed share buyback to be in the overall best interests of the company and its shareholders [1]
德琪医药-B拟回购最多4000万港元股份